Lack of association between the BIM deletion polymorphism and the risk of lung cancer with and without EGFR mutations.
Ebi H, Oze I, Nakagawa T, Ito H, Hosono S, Matsuda F, Takahashi M, Takeuchi S, Sakao Y, Hida T, Faber AC, Tanaka H, Yatabe Y, Mitsudomi T, Yano S, Matsuo K.
Ebi H, et al. Among authors: yatabe y.
J Thorac Oncol. 2015 Jan;10(1):59-66. doi: 10.1097/JTO.0000000000000371.
J Thorac Oncol. 2015.
PMID: 25384174
Free article.